Ascendis Pharma
ASND
#1252
Rank
A$26.72 B
Marketcap
A$407.38
Share price
3.12%
Change (1 day)
22.90%
Change (1 year)

Earnings for Ascendis Pharma (ASND)

Earnings in 2026 (TTM): A$0.35 Billion

According to Ascendis Pharma 's latest financial reports the company's current earnings are A$1.21 Billion. In 2025 the company made an earning of -A$0.19 Billion, an increase over its 2024 earnings that were of -A$0.43 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Ascendis Pharma from 2014 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) A$0.35 B-297.35%
2025 -A$0.19 Billion-57.34%
2024 -A$0.43 Billion-37.13%
2023 -A$0.68 Billion-13.46%
2022 -A$0.79 Billion23.12%
2021 -A$0.64 Billion-10.49%
2020 -A$0.71 Billion104.55%
2019 -A$0.35 Billion61.09%
2018 -A$0.22 Billion1.03%
2017 -A$0.22 Billion89.6%
2016 -A$0.12 Billion104.12%
2015 -A$54.98 Million185.04%
2014 -A$19.29 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Akebia Therapeutics
AKBA
-A$63.88 Million-117.31%๐Ÿ‡บ๐Ÿ‡ธ USA
Affimed
AFMD
-A$0.12 Billion-130.66%๐Ÿ‡ฉ๐Ÿ‡ช Germany
Advaxis
ADXS.defunct
-A$50.34 Million-113.64%๐Ÿ‡บ๐Ÿ‡ธ USA